What are the contraindications and required dose adjustments for oseltamivir (Tamiflu)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Contraindications and Dose Adjustments for Tamiflu (Oseltamivir)

The only absolute contraindication to oseltamivir is known serious hypersensitivity to oseltamivir or any component of the formulation 1. Beyond this, dose adjustments are required for renal impairment, and special considerations apply to specific age groups.

Contraindications

  • Serious hypersensitivity reactions: This includes anaphylaxis or severe allergic reactions to oseltamivir or any excipients 1
  • No other absolute contraindications exist in current FDA labeling or guidelines

Important Safety Warnings (Not Contraindications)

While not contraindications, be aware of:

  • Neuropsychiatric events: Patients with influenza, particularly children, may experience confusion or abnormal behavior. Monitor closely, though recent evidence suggests oseltamivir may actually reduce these events (IRR 0.53) 2
  • Serious skin reactions: Discontinue immediately if allergic-like reactions occur 1

Dose Adjustments for Renal Impairment

For adults with creatinine clearance 10-30 mL/min 3, 4:

  • Treatment: 75 mg once daily for 5 days (reduced from twice daily)
  • Prophylaxis: Either 30 mg once daily OR 75 mg every other day for 10 days after exposure

For creatinine clearance <10 mL/min: Oseltamivir is not recommended in FDA labeling, though specialized dosing exists for dialysis patients 5:

  • Hemodialysis patients: 30 mg after alternate dialysis sessions (three times weekly)
  • CAPD patients: 30 mg once weekly after dialysate exchange

Critical Pitfall in Renal Dosing

Current renal dosing recommendations focus on steady-state concentrations but may delay achievement of therapeutic levels early in infection when treatment is most critical 6. For patients with mild-to-moderate renal impairment, consider giving the first dose at 75 mg (standard dose) to rapidly achieve therapeutic concentrations, then reduce subsequent doses based on creatinine clearance 6.

Age-Based Dosing and Special Populations

Standard Pediatric Dosing (≥12 months) 4, 7

Treatment (twice daily for 5 days):

  • ≤15 kg: 30 mg

  • 15-23 kg: 45 mg

  • 23-40 kg: 60 mg

  • 40 kg: 75 mg

Prophylaxis (once daily for 7-10 days): Same doses as treatment, but once daily

Infants 9-11 Months 4, 7

  • Treatment: 3.5 mg/kg/dose twice daily
  • Prophylaxis: 3.5 mg/kg/dose once daily

Term Infants 0-8 Months 4, 7

  • Treatment: 3 mg/kg/dose twice daily
  • Prophylaxis: 3 mg/kg/dose once daily for ages 3-8 months; NOT recommended for <3 months unless situation is critical due to limited safety data

Preterm Infants 4, 7

Dose based on postmenstrual age (PMA = gestational age + chronological age):

  • <38 weeks PMA: 1 mg/kg/dose twice daily
  • 38-40 weeks PMA: 1.5 mg/kg/dose twice daily
  • >40 weeks PMA: 3 mg/kg/dose twice daily

Critical caveat: Preterm infants have immature renal function and slower oseltamivir clearance. Standard term infant doses can lead to dangerously high drug concentrations 3, 7. For extremely preterm infants (<28 weeks), consult pediatric infectious disease.

Elderly Patients (≥65 Years)

No dose adjustment based on age alone 8. However, renal function declines with age, so assess creatinine clearance and adjust accordingly.

Administration Considerations

  • Can be given without regard to meals, though administration with food may reduce nausea 4, 1
  • Available formulations: 30 mg, 45 mg, 75 mg capsules; 6 mg/mL oral suspension 4, 1
  • If suspension unavailable: Capsules can be opened and mixed with sweetened liquid, or pharmacies can compound suspension 3, 4
  • For infants <1 year: Use appropriate measuring device (3-mL or 5-mL oral syringe), not the standard syringe supplied 4

Key Clinical Pearls

  1. Timing is everything: Oseltamivir must be initiated within 48 hours of symptom onset for treatment, and within 48 hours of exposure for prophylaxis 4

  2. Not a vaccine substitute: Oseltamivir is an adjunct to, not replacement for, annual influenza vaccination 4, 1

  3. Resistance monitoring: While most strains remain susceptible, H275Y mutation in H1N1pdm09 confers resistance 3, 9

  4. Drug interaction: Do not administer live attenuated influenza vaccine (LAIV) until 48 hours after stopping oseltamivir; conversely, do not give oseltamivir until 2 weeks after LAIV unless medically necessary 1

  5. Large body mass: Patients with significantly elevated body mass may require proportionately higher first doses to achieve rapid therapeutic concentrations 6

References

5
Research

The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006

9
Research

Considerations when treating influenza infections with oseltamivir.

Expert opinion on pharmacotherapy, 2024

Related Questions

What is the recommended dosing of oseltamivir for influenza treatment and prophylaxis in adults, children, and patients with renal impairment?
What is the recommended adult dose of oseltamivir (Tamiflu) for treating influenza and for post‑exposure prophylaxis, and how should the dose be adjusted in renal impairment?
What follow‑up schedule and monitoring are recommended after initiating oseltamivir in a patient on hemodialysis or peritoneal dialysis for influenza treatment or prophylaxis?
What is the recommended oseltamivir (Tamiflu) dosing for children, including infants under one year, for treatment and prophylaxis, and how should the dose be adjusted in renal impairment?
What are the indications, dosing regimens, contraindications, adverse effects, and renal dose adjustments for oseltamivir (Tamiflu) in patients aged one year and older?
What antibiotic should be used for suspected epididymitis if ceftriaxone and doxycycline fail to improve symptoms?
In a reproductive‑age woman with known bowel endometriosis, can the disease cause an elevated fecal calprotectin level?
What is the recommended management for postoperative ileus?
Are ASCE (adipose stromal cell‑derived) exosomes an effective and safe option for hair restoration in adults with androgenetic alopecia?
What is the likely diagnosis and recommended treatment for persistent rhinorrhea, cough, sore throat, and headache?
What are the indications and side effects of metformin in a healthy 20‑year‑old woman, can it promote weight loss, and what pharmacologic and non‑pharmacologic weight‑control measures should be used alongside it?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.